Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Upcoming Science Board meeting

This article was originally published in The Tan Sheet

Executive Summary

FDA's Science Board will review the agency's progress on rapidly detecting salmonella in food during a public meeting May 18 in Rockville, Md. The agency prioritized detecting salmonella in food during the March Science Board meeting in response to the 2007 jalapeno pepper contamination (1"The Tan Sheet" March 2, 2009, p. 8). The board also will review the agency's information technology infrastructure modernization, which the board said was so inadequate it hindered FDA's ability to fulfill its mission (2"The Tan Sheet" Dec. 17, 2007, p. 10). FDA's centers also will update the board on their scientific priority areas

You may also be interested in...



FDA Prioritizes Rapid Detection Of Food Contaminants

FDA has made a top priority of developing methods to rapidly detect food-borne contaminants and is working with other agencies to identify effective systems

Advisors Say FDA Funding Fails Science, Senators Pan Food Safety Plan

Members of the Senate say FDA's Food Protection Plan is not sufficient to improve the current U.S. food safety system, but an FDA advisory board says without additional resources "substantial weaknesses across the agency" will continue

QUOTED. 22 September 2020. Francis deSouza.

Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.

Topics

UsernamePublicRestriction

Register

ID1122310

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel